What is the debt of Fagron this year?
Fagron has a debt level of 233.74 EUR this year.
Fagron Debt 2024
Fagron Debt
233.74 EUR
Ticker
FAGR.BR
ISIN
BE0003874915
WKN
A0M103
In 2024, Fagron's total debt was 233.74 EUR, a 56.48% change from the 149.38 EUR total debt recorded in the previous year.
Fagron Aktienanalyse
What does Fagron do?
Fagron NV is an internationally operating company that focuses on the development and production of customized medications for pharmacies and hospitals. The company was founded in 1990 in Rotterdam, Netherlands. The beginnings of Fagron NV were in the Netherlands, where the company was established as Roterodamum Chemie BV. In the late 1990s, the company was converted into a holding company called Arseus NV, which later received the name Fagron. In 2012, Fagron was listed on the Euronext stock exchange in Brussels. Fagron operates globally and has locations in Europe, North America, Latin America, the United Arab Emirates, Asia, and Australia. Fagron's business model is based on the production of specialized medications for individual patient needs. The company offers a wide range of pharmaceutical active ingredients, raw materials, and processing services. There is also the possibility to develop and manufacture customized formulations tailored to the needs of patients. Fagron not only manufactures customized medications but also provides training and support for pharmacies and hospitals. Fagron operates in three main divisions: Specialty Pharma (hospital care), Community Pharma (prescription and non-prescription medications), and Compounding Services (custom formulations). The Specialty Pharma division specializes in medications for use in hospitals. It offers a wide range of products that can be used in the treatment of conditions such as cancer, HIV, and tuberculosis. These medications are manufactured in various dosage forms, such as injections, infusions, and tablets. The Community Pharma division focuses on prescription and non-prescription medications. Both branded and generic medications are offered. These are delivered directly to pharmacies, hospitals, and clinics. The Compounding Services division specializes in the production of customized medications. Fagron works closely with pharmacies and hospitals to meet individual needs. This includes, for example, the manufacture of medications in specific dosages or the combination of several active ingredients in a custom formulation. Fagron offers a wide range of products, including hormones, pain medications, cancer drugs, medications for the treatment of skin diseases, ophthalmic products, and anti-infectives. Pharmaceutical active ingredients and raw materials are also offered. Overall, Fagron is a global leader in the production of customized medications. It has extensive experience and expertise in the manufacturing of pharmaceutical formulations and offers a wide range of products and services. The various divisions of Fagron allow the company to meet the diverse needs of its customers and maintain its position as a leading company in the pharmaceutical industry. Fagron ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Fagron's Debt Structure
Fagron's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Fagron's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Fagron’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Fagron’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Fagron stock
What was the debt of Fagron compared to the previous year?
The debt of Fagron has increased by 56.48% compared to the previous year increased.
What are the consequences of high debt for investors in Fagron?
High debt can pose a risk for investors of Fagron, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Fagron?
Low debt means that Fagron has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Fagron affect the company?
An increase in debt of Fagron can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Fagron affect the company?
A reduction in debt of Fagron can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Fagron?
Some factors that can influence the debt of Fagron include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Fagron so important for investors?
The debts of Fagron are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Fagron take to change the debt?
To change the debt, Fagron can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Fagron pay?
Over the past 12 months, Fagron paid a dividend of 0.25 EUR . This corresponds to a dividend yield of about 1.36 %. For the coming 12 months, Fagron is expected to pay a dividend of 0.28 EUR.
What is the dividend yield of Fagron?
The current dividend yield of Fagron is 1.36 %.
When does Fagron pay dividends?
Fagron pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Fagron?
Fagron paid dividends every year for the past 0 years.
What is the dividend of Fagron?
For the upcoming 12 months, dividends amounting to 0.28 EUR are expected. This corresponds to a dividend yield of 1.55 %.
In which sector is Fagron located?
Fagron is assigned to the 'Health' sector.
Wann musste ich die Aktien von Fagron kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Fagron from 5/23/2024 amounting to 0.3 EUR, you needed to have the stock in your portfolio before the ex-date on 5/21/2024.
When did Fagron pay the last dividend?
The last dividend was paid out on 5/23/2024.
What was the dividend of Fagron in the year 2023?
In the year 2023, Fagron distributed 0.2 EUR as dividends.
In which currency does Fagron pay out the dividend?
The dividends of Fagron are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Fagron
Our stock analysis for Fagron Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fagron Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.